HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brooke Esteves Selected Research

RN909

11/2018Single and multiple ascending-dose study of glucagon-receptor antagonist RN909 in type 2 diabetes: a phase 1, randomized, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brooke Esteves Research Topics

Disease

3Hypertension (High Blood Pressure)
03/2015 - 11/2011
3Neoplasms (Cancer)
03/2015 - 11/2011
2Diarrhea
11/2018 - 10/2013
2Fatigue
03/2015 - 11/2011
2Renal Cell Carcinoma (Grawitz Tumor)
10/2013 - 05/2012
1Type 2 Diabetes Mellitus (MODY)
11/2018
1Neutropenia
03/2015
1Dizziness (Lightheadedness)
03/2015
1Dysphonia (Spastic Dysphonia)
10/2013

Drug/Important Bio-Agent (IBA)

4tivozanibIBA
03/2015 - 11/2011
2Tyrosine Kinase InhibitorsIBA
03/2015 - 10/2013
2Transaminases (Aminotransferases)IBA
03/2015 - 11/2011
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
10/2013 - 05/2012
1RN909IBA
11/2018
1Monoclonal AntibodiesIBA
11/2018
1Glucagon Receptors (Glucagon Receptor)IBA
11/2018
1Leucovorin (Folinic Acid)FDA Link
03/2015
1Fluorouracil (Carac)FDA LinkGeneric
03/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2015
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2015
1Sorafenib (BAY 43-9006)FDA Link
10/2013
1Phosphotransferases (Kinase)IBA
11/2011
1Biological ProductsIBA
11/2011
1Tyrosine (L-Tyrosine)FDA Link
11/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2011

Therapy/Procedure

1Therapeutics
10/2013